Skip to main content
. 2017 Nov 6;8(65):108859–108866. doi: 10.18632/oncotarget.22313

Table 3. Allele frequencies in cases and controls and odds ratio estimates for ONFH.

SNP ID Gene Position Alleles A/B MAF pa value for HWE ORs 95% CI pb
Case Control
rs639752 MMP3 11q22.2 C/A 0.32 0.35 0.116 0.88 0.74 1.06 0.177
rs650108 MMP3 11q22.2 G/A 0.39 0.44 0.147 0.84 0.70 0.99 0.040*
rs520540 MMP3 11q22.2 A/G 0.32 0.35 0.116 0.88 0.74 1.06 0.177
rs646910 MMP3 11q22.2 A/T 0.07 0.09 1 0.82 0.60 1.13 0.224
rs602128 MMP3 11q22.2 A/G 0.32 0.34 0.235 0.90 0.75 1.07 0.234
rs679620 MMP3 11q22.2 T/C 0.32 0.35 0.202 0.88 0.74 1.05 0.156
rs678815 MMP3 11q22.2 G/C 0.32 0.35 0.141 0.88 0.74 1.05 0.165
rs522616 MMP3 11q22.2 C/T 0.40 0.35 0.923 1.20 1.00 1.42 0.044*

SNP single nucleotide polymorphism, HWE Hardy-Weinberg equilibrium, OR odds ratio, 95% CI 95% confidence interval, MAF minor allele frequency.

* p ≤ 0.05 indicates statistical significance.

a p was calculated by exact test.

bp was calculated by Pearson Chi-squared test.